Personalized mRNA Cancer Vaccine Cuts Melanoma Recurrence Risk by 42% 25 October 2026·1714 words·9 mins MRNA Vaccine Cancer Immunotherapy Melanoma Personalized Medicine Moderna Merck Neoantigens Clinical Trials
